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Exposures that contribute to a sub-optimal intrauterine environment can have an effect on the 
developing fetus. Impaired fetal growth that results in low birth weight is an established risk 
factor for cardio-metabolic disorders later in life. Recent epidemiologic and prospective cohort 
studies that include the maternal and gestational period have identified maternal and gestational 
conditions that confer increased risk for subsequent cardio-metabolic disorders in the absence 
of low birth weight. Maternal pre-conception health status, including chronic obesity and type 2 
diabetes increase risk for childhood obesity and obesity related higher blood pressure (BP) in 
child offspring. Maternal gestational exposures including gestational diabetes, gestational 
hypertension, and preeclampsia are associated with higher BP in offspring. Other maternal 
exposures such as cigarette smoke and air pollution also increase risk for higher BP in child 
offspring. Recent, but limited, data indicate that assisted reproductive technologies can be 
associated with hypertension in childhood, despite otherwise normal gestation and healthy 
newborn. Gestational exposures associated with higher BP in childhood can be related to 
genetics, familial life-style factors, or could also be a consequence of fetal programing. Current 
and developing research will provide additional insights on gestational exposures and fetal 



















In the prenatal period, the intrauterine environment is critical for optimal fetal growth and organ 
development. Exposures due to a sub-optimal intrauterine environment can alter the 
developmental pathway in the fetus in ways that can affect extra-uterine health status later in 
life. Low birth weight has become an established risk factor for subsequent metabolic and 
cardiovascular disorders in childhood and in later adulthood. This relationship has been 
confirmed mainly by large epidemiologic studies on adult populations or cohorts with access to 
birth records. Experimental studies developed animal models to replicate a compromised 
intrauterine environment.1,2 These models demonstrate that the timing of perturbations in the 
intrauterine environment have an adverse effect on the fetus that is related to impaired health 
status in extra-uterine life. Subsequent epidemiologic studies investigated maternal conditions, 
both prior to conception and perinatal, that could confer a shift in the intrauterine environment to 
one that is suboptimal for the developing fetus. It is now known that these exposures can have 
an effect on offspring in childhood and later adulthood that is independent of birth weight. This 
review will discuss the current state of knowledge on maternal and gestational conditions that 
influence suboptimal health outcomes in offspring. Other environmental maternal perinatal 
exposures will be discussed that may have an effect on intrauterine conditions leading to 
chronic cardiovascular and metabolic health consequences in offspring.  This review will focus 
on maternal and gestational conditions and exposures that appear to have a direct or indirect 
effect on blood pressure (BP) in childhood. Recent clinical studies on low birth weight that 
provide insights on the development of hypertension in childhood or later adulthood due to fetal 
programing will also be reviewed.   
 
Maternal Obesity and Diabetes Mellitus; 
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 Maternal obesity prior to pregnancy is now recognized as a risk factor for development 
of obesity in childhood regardless of birth weight.3-6 Blood pressure (BP) levels are higher in 
overweight and obese child offspring of maternal obesity compared to non-obese children.7 In a 
study on mother-offspring pairs from a prospective pregnancy cohort, gestational weight gain 
(GWG) was monitored throughout pregnancy and offspring were examined at age 9 years. 
Mothers who exceeded the recommended GWG were more likely to have offspring with greater 
body mass index (BMI) with greater total fat mass, higher plasma leptin and C-reactive protein, 
and higher systolic BP.  Data from other studies also report higher systolic BP in early childhood 
among offspring of mothers with greater maternal pre-pregnancy adiposity and greater GWG up 
to 36 weeks gestation.4,8 The higher BP levels among obese offspring are associated with 
relative insulin resistance and reflect components of metabolic syndrome.  Therefore, it is 
difficult to determine if the abnormal cardio-metabolic outcomes in offspring of maternal obesity 
are a consequence of fetal programing or are directly related to the childhood obesity resulting 
from post-natal family environment.9  A study by Gaillard et al.10 sought to determine if the 
associations of pre-pregnancy obesity with adverse cardiovascular risk factors in offspring was 
mediated by heredity, familial lifestyle or intrauterine mechanisms. In a population-based 
prospective cohort study, the investigators examined mothers, fathers, and their children to 
investigate associations of both maternal and paternal pre-pregnancy BMI with cardio-metabolic 
outcomes in children at age 6 years. Higher pre-pregnancy maternal and paternal BMI were 
associated with higher childhood BMI, total body and abdominal fat mass, systolic BP, insulin 
levels, and lower high-density lipoprotein cholesterol levels. The associations were stronger for 
maternal pre-pregnancy BMI than paternal pre-pregnancy BMI. The stronger associations with 
maternal pre-pregnancy BMI with offspring risk factors suggested the outcomes could be 
mediated by intrauterine mechanisms. Although maternal obesity is clearly associated with 
offspring obesity and elevated BP, the evidence for fetal programing of adverse BP and 
metabolic outcomes in offspring is largely based on experimental models.11  Moreover, a recent 
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study conducted by the Pregnancy and Childhood Epigenetics (PACE) consortium, examined 
epigenetic modifications such as DNA methylation in fetal cord blood to determine if there were 
associations with maternal pre-pregnancy BMI. In this well powered study of over 10,000 
mother-newborn pairs, the association of newborn blood DNA methylation with maternal BMI 
were minimal, indicating that the relationship of maternal obesity with adverse cardio-metabolic 
risk factors, including elevated BP, in offspring were more likely due to genetic or lifestyle 
factors.12     
 
Insulin resistance is common in both maternal diabetes and maternal obesity and both 
conditions express risks associated with excess adiposity. However, gestational hyperglycemia 
can augment the risk for adverse outcomes in offspring.  To determine the offspring risk for 
development of diabetes following intrauterine hyperglycemia, Dabelea et al.13 examined young 
adult sibling pairs in which one was born before the mother developed diabetes and the other 
sibling was born after the mother had become diabetic and was exposed to hyperglycemia in 
utero. The risk of diabetes was significantly higher in siblings born after the mother developed 
diabetes (odds ratio 3.7, P = 0.02).  The mean BMI is also significantly higher among siblings 
exposed to maternal diabetes compared to siblings born before the mother developed 
diabetes.14 Development of excess adiposity appears to be the seminal risk factor among 
offspring exposed to maternal hyperglycemia and is detectable in early childhood.15 Data from 
the EPOCH (Exploring Perinatal Outcomes in Children) study examined BMI growth trajectories 
from birth to age 13 years.  BMI growth was not significantly different between exposed and 
unexposed infants up to 26 months.  From 27 months through age 13 years BMI growth was 
significantly greater among offspring exposed to maternal hyperglycemia compared to 
unexposed offspring (P = 0.005).16 Concurrent with childhood obesity, other related cardio-
metabolic risk factors are found in offspring of maternal diabetes, including gestational 
diabetes.17 In addition to findings of relative insulin resistance, higher BP at mean age 15 
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years,18 age 7 years,19 and age 3 years20 are reported in offspring exposed to intrauterine 
hyperglycemia compared to unexposed offspring.  A meta-analysis of 13 studies on diabetic 
pregnancy and offspring BP in childhood reported significantly higher systolic BP in offspring of 
diabetic mothers. The association of higher BP in offspring of diabetic pregnancy was stronger 
in boys than girls.21  Overall, both maternal obesity and maternal diabetes confer heightened 
risk on offspring for obesity, insulin resistance, and higher BP 
 
Maternal Hypertension: 
Recent reports on associations of maternal hypertension during pregnancy with offspring BP 
describe a significant positive association. However, in earlier reports, the leading factor in 
predicting future BP in offspring was low birth weight,22 or low birth weight combined with 
overweight in childhood.23 In a large study by Vatten et al.24 female adolescent girls, age 13 to 
19 years were stratified as offspring of preeclamptic pregnancies or normotensive pregnancies. 
Offspring of preelamptic pregnancies had significantly higher systolic BP and diastolic BP, and 
also significantly higher BMI in adolescence. After adjustment for BMI, the differences in systolic 
and diastolic BP were no longer significant. The authors concluded that the intrauterine 
exposure to preeclampsia could be causally related to later hypertension but may be 
confounded by higher BMI during adolescence. A somewhat later meta-analysis of published 
reports on preeclampsia and offspring BP concluded that nearly all studies demonstrate higher 
BP in offspring of women with preeclampsia, in the range of 2 to 3 mmHg systolic pressure. 
However, the authors noted considerable differences in definition of preeclampsia and potential 
relevant maternal factors such as age, severity of preeclampsia, maternal BMI, parity, and 
socio-economic status that should be considered in developing causal relationships between 
maternal preeclampsia and offspring BP.25  
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Subsequent studies examined BP in offspring of mothers with preeclapsia and also offspring of 
mothers with gestational hypertension. Investigators in the Avon Longitudinal Study of Parents 
and Children examined data of 6343 offspring participants at age 9 years. Using rigorous 
definitions of hypertensive disorders of pregnancy, mothers were categorized as normotensive 
pregnancy (N= 5,345), Gestational hypertension (N= 1,118), or preeclampsia (N= 205).  
Mothers who had a previous diagnosis of hypertension prior to pregnancy were excluded from 
analysis.  Compared to offspring of normotensive pregnancy, systolic BP was higher in offspring 
of preeclampsia (2.05 mmHg {95% CI; 1.72, 3.38}) and also in offspring of gestational 
hypertension (2.04 mmHg {95% CI; 1.42, 2.67}). Diastolic BP was also significantly higher 
among offspring of preeclampsia (1.00 mmHg {95% CI; -0.01, 2.10}) and offspring of gestational 
hypertension (1.07 mmHg {95% CI; 0.60, 1.54}). Following adjustment for birth weight and 
gestational age, the association of preeclampsia with offspring systolic and diastolic BP 
attenuated and became non-significant. However, these adjustments did not attenuate the 
association of gestational hypertension with higher offspring BP.26  In another report on this 
cohort, investigators examined offspring of preeclampsia, gestational hypertension, and 
normotensive pregnancies at offspring age 9 to 12 years. In addition to BP, other measures of 
vascular function and structure were obtained in the offspring, including brachial artery flow 
mediated dilation, pulse wave velocity, and brachial artery distensibility.  Markers of 
inflammation, and lipids were also measured. Following adjustments for maternal and offspring 
BMI, offspring dietary sodium intake, and other potential confounders, significantly higher 
systolic and diastolic BP was detected in both offspring of preeclampsia and offspring of 
gestational pregnancy compared to offspring of normotensive pregnancy. No associations were 
detected among offspring of either hypertensive disorder of pregnancy with the other vascular 
function measures or with inflammatory markers or lipids. The authors concluded that the 
association of offspring BP with preeclampsia and with gestational hypertension are consistent 
with the presence of shared mother-offspring risk factors specific for higher BP, rather than 
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additional cardio-metabolic abnormalities specifically due fetal exposure to maternal 
hypertension.27  A portion (N=4438) of this cohort was re-examined at a mean age of 17 years 
and included offspring of preeclampsia (N=53) and gestational hypertension (N=431) as well as 
offspring of normotensive pregnancy. In addition to BP and BMI, fasting insulin, glucose, and 
lipids were measured. The results again demonstrated significantly higher systolic and diastolic 
BP among offspring of preeclampsia and offspring of gestational hypertension compared to 
offspring of normotensive pregnancy, following adjustment for potential confounders of age, sex, 
maternal age at delivery, social-economic class, pre-pregnancy BMI, and smoking in pregnancy. 
There were no differences in insulin, glucose, or lipids detected between offspring of maternal 
hypertension and offspring of normotensive mothers. These results suggested that the positive 
association between maternal hypertensive disorders of pregnancy with offspring BP may be 
mediated by genetics or familial non-genetic risk factors related to BP.28  Moreover, the 
differences in BP levels between offspring of hypertensive pregnancies and offspring of 
normotensive pregnancies remain consistent from childhood through adolescence.29  
 
Other studies have reported similar findings.  Miettole et al.30 examined data from the Northern 
Finland Birth Cohort on offspring at mean age 16 years. They reported higher systolic BP in 
offspring of gestational hypertension with a tendency for higher cholesterol and apolipoprotein B 
values compared to offspring of normotensive mothers.  Offspring of preeclampsia had higher 
BP compared to offspring of normotensive mothers; however, this difference was no longer 
significant following adjustments for confounders. Clinically, preeclampsia is different than 
gestational hypertension. It remains unclear if the offspring outcomes are also different.  A 
recent systematic review, that included 18 studies, determined that offspring of preeclampsia 
have significantly higher systolic BP, diastolic BP, and higher BMI compared to offspring of 
normotensive pregnancies.31 In a smaller study, BP characteristics of offspring of mothers with 
early onset preeclampsia (before 34 weeks gestation) were compared to offspring of mothers 
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with late onset preeclampsia. At age 6 to 13 years, systolic BP was significantly higher in 
offspring of early onset preeclampsia compared to offspring of late onset preeclampsia.32   
 
Additional insights on offspring outcomes of hypertensive disorders of pregnancy are conveyed 
in a report on data from the HUNT study (Nord-Trondelag Health study) in Norway. This cohort 
includes 15,778 offspring participants at mean age 29 years, and includes 210 sibling groups. 
BP, anthropometrics, lipids, and C-reactive protein were measured. The offspring exposed to 
maternal hypertension in pregnancy included 336 exposed to gestational hypertension, 343 
exposed to term preeclampsia, and 27 exposed to preterm preeclampsia.  Offspring exposed to 
hypertension in pregnancy had significantly higher levels of systolic and diastolic BP compared 
to offspring of normotensive pregnancies. It is notable that the difference in BP levels among 
offspring exposed to hypertensive pregnancy compared to offspring unexposed are at levels 
quite similar to that described in the childhood reports cited above.  Offspring exposed to 
hypertension in pregnancy also had higher BMI and greater waist circumference than offspring 
of normotensive pregnancies. The differences in BP and BMI were similar in offspring of 
gestational hypertension and offspring of term preeclampsia, compared to offspring of 
normotensive pregnancy.  The striking finding in this study was the outcomes among siblings. 
Siblings who were born to a mother with a normotensive pregnancy had a cardiovascular risk 
profile, including BP and BMI, that was similar to their sibling who was exposed to a 
hypertensive pregnancy. These findings indicate that the cardiovascular risk, manifest by higher 
BP and other BP related risk factors could be attributed to shared genetic factors with the 
mother and shared environmental factors.33  The offspring in the preterm preeclampsia group 
were all premature, based on gestational age, and had low birth weight. The authors provide 
little mention of this group other that the sample size was too small to analyze separately. The 
overall evidence indicates that both maternal gestational hypertension and preeclampsia are 
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conditions that increase risk for high BP in offspring, regardless of birth weight, and the risk for 
elevated BP is heightened with development of excess adiposity in childhood. 
 
Other Exposures During Gestation: 
 
A maternal behavior that is considered to have an adverse effect on offspring later in life is 
smoking during pregnancy.  An investigation on 8815 adult participants of the 1958 British Birth 
Cohort detected a link between maternal smoking during pregnancy and offspring adiposity.  
The investigators measured cardiovascular risk parameters in offspring participants at mean 
age 45 years. Compared to offspring of non-smokers, offspring of smokers had higher BMI, 
waist circumference, systolic and diastolic BP, HbA1c and triglycerides. Following adjustment 
for post-natal factors, BP and metabolic risk factors were no longer significant.  However, mean 
BMI and waist circumference remained significantly higher in offspring of mothers who smoked 
during pregnancy compared to non-smokers. Mean BMI and waist circumference increased with 
the number of cigarettes the mother smoked, but were not elevated among offspring of mothers 
had quit smoking before or early in pregnancy.34  Similar data on offspring following prenatal 
exposure to maternal smoking was also reported in children.  Oken et al.35 investigated 746 
mother-child pairs in Project Viva, a prospective cohort study.  Mothers were stratified as never 
smokers (69%), early pregnancy smokers (10%), or former smokers (22%). Child offspring were 
examined at age 3 years.   Compared to offspring of never smokers, offspring of early 
pregnancy smokers had increased risk for excess adiposity and significantly higher BMI z-score 
and higher systolic BP (2.4 mm Hg; 95% CI, -0.1, 4.9).  Offspring of former smokers were not 
more overweight than offspring of never smokers, but had higher systolic BP (1.5 mm Hg; 95% 
CI, -0.1, 3.2). While both offspring of former smokers and offspring of early pregnancy smokers 
had higher BP compared to offspring of never smokers, offspring of former smokers did not 
manifest excess adiposity.  Whether the BP and BMI patterns remain different in later childhood 
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is not known. Oken et al.36 also conducted a systematic review and meta-analysis on 14 
observational studies on offspring (ages 3-33 years) whose mothers smoked during pregnancy. 
Overall, child offspring of mothers who smoked during pregnancy were at higher risk for 
overweight compared to offspring of mothers who did not smoke during pregnancy (pooled 
adjusted odds ratio 1.50; 95% CI, 1.36, 1.65). Effect of prenatal smoking on offspring BP was 
not addressed in this meta-analysis.  A direct effect of maternal smoking during pregnancy on 
offspring BP has not been confirmed.  However, the significant association of maternal smoking 
during pregnancy with heightened risk for obesity in offspring suggest that offspring could have 
higher BP related to obesity.  Considering the established adverse health effects of cigarette 
smoke exposure in children and adults, prenatal smoking is strongly discouraged. 
 
In addition to cigarette smoke, there are other inhaled maternal exposures that could have an 
adverse effect on offspring BP. Particulate matter inhalation from air pollution is reported to be 
significantly associated with hypertensive disorders of pregnancy,37 and preterm birth,38 two 
conditions linked with higher BP in offspring.  Reports on air pollution and pregnancy outcomes 
from Canada describe an association between particulate matter exposure and low 
birthweight,39 and an association of particulate matter with preterm birth that was stronger 
among women with pre-existing diabetes, asthma, and preeclampsia.40  A relationship of 
maternal exposure to ambient particulate matter during pregnancy and risk for high BP in 
childhood was investigated prospectively in a cohort of mothers in the Boston Birth Study (N = 
1293) and their offspring.  Offspring were examined between age 3 to 9 years.  Analysis of 
study data identified a marked increase in offspring systolic BP percentile and elevated BP 
when third trimester particulate matter exposure (PM2.5) was >13ug/m3 (highest tertile of 
PM2.5).41 A recent study described a significant association of maternal prenatal air pollution 
exposure, specifically the particle nitrogen dioxide (NO2), with newborn cord blood DNA 
methylation.42 Another study, conducted on participants in the Children’s Health Study (N = 
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459), examined prenatal exposure to NO2 and other particulate matter pollutants, with DNA 
methylation in cord blood samples of offspring, and childhood BP. The investigators reported 
that NO2 exposure in the third trimester, compared to other prenatal periods, was associated 
with greater DNA methylation and higher BP levels in 11 year old children.43] This study 
suggested that childhood BP outcomes were related to the gestational timing of fetal exposure 
to particulate matter in air pollution.  
 
 Other chemicals are being investigated for possible relationships with cardio-metabolic 
risk factors in childhood.  Phthalates and bisphenols are environmental chemicals commonly 
used in consumer and personal care products.   These chemicals and their metabolites are 
considered to be possible endocrine disrupting chemicals. Trasande and Attina44 conducted a 
cross-sectional study on a sub-sample of children who were participants in the National Health 
and Nutrition Examination Survey 2009-2012 that included an assay of urine samples for 
metabolites of phthalates. In urine samples from children 6 to 19 years of age, metabolites of 
low molecular weight phthalates were significantly associated with higher systolic BP z-score in 
univariate analysis, but the association was no longer significant following multivariable 
adjustment.  A study that measured urinary concentrations of phthalate and bisphenol 
metabolites in pregnant women found that measureable levels of these metabolites were 
commonly detected.45  Despite several studies on these chemical compounds, some of which 
describe and adverse effect of prenatal and childhood exposure on child growth and cardio-
metabolic outcomes, the results of some studies are inconclusive. Further prospective studies 
are needed to determine if there are quantifiable risks on offspring following prenatal 
exposure.46 
 
 Assisted reproductive technologies (ART) may be another type of maternal exposure 
that could have an effect on offspring BP.  ART is a relatively new, but increasingly used, 
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strategy in fertility treatment. Little is data are available on long term outcomes of children 
conceived by ART and result in term pregnancies with apparently healthy children.  Scherrer et 
al.47 conducted a study to investigate vascular function on healthy early adolescents (mean age 
11.5 years) who were products of a term pregnancy following maternal ART.  Children exposed 
to ART were matched by age, sex, BMI, and social status with children who were term offspring 
of normal pregnancy. ART cases that involved maternal complications including preeclampsia 
were excluded. Children conceived by ART had significantly greater endothelial dysfunction 
(lower brachial artery dispensability), significantly higher PWV, and carotid thickness compared 
to controls. However, there were no differences in clinic BP levels and elevated BP was not 
noted.  Concurrent experimental studies, by these investigators, on mice found that mice 
conceived by ART had endothelial dysfunction and increased vascular stiffness with resulting 
hypertension and premature death.  ART mice also had altered methylation of genes involved in 
vascular nitric oxide production. These experimental findings were consistent with accelerated 
vascular ageing in products of ART on conception.48 In a 4-year follow-up study on the ART 
conceived healthy adolescents and controls, participants were recalled at age 16 years and 24-
hour ambulatory BP monitoring was performed. Clinic BP levels were not provided in this report.  
24-hour mean systolic and diastolic BP was significantly higher in the ART conceived 
adolescents compared to control; and 15.4% of ART conceived adolescents met criteria for 
hypertension compared to 2.5% of controls.49  Although the data are limited, these findings are 
sufficiently compelling to add ART to the prenatal history of children with hypertension and 
without typical risk factors. Further research is needed to determine if hypertension and 
evidence of cardiovascular dysfunction can be linked with ART. 
 
Low Birth Weight: 
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Following the seminal observation by Barker et al.50 many epidemiologic studies have 
demonstrated a link between lower birth weight and adverse cardio-metabolic outcomes in later 
adulthood. Some of the maternal conditions discussed above, especially preeclampsia, 
heighten risk for premature delivery as well as lower birth weight for gestational age. Other 
identified causes of low birth weight include mechanical obstruction of uterine arteries, maternal 
corticosteroid treatment, and severe protein deficiency.11  The recognized adverse outcomes of 
low birth weight later in life are metabolic and cardiovascular. For example, a systematic review 
of population studies found that, in most populations, birth weight was inversely related to the 
risk for type 2 diabetes in adulthood.51  Young adults, age 18 to 27 years born preterm with very 
low birth weight (<1500 gm) have significantly more impaired glucose tolerance and higher BP 
compared to age/sex matched individuals born at term with normal range birth weight.52   
Experimental models designed to impair the intrauterine environment, resulting in low birth 
weight, provide plausible mechanistic pathways indicating that low birth weight is a marker of 
fetal programing.1,2  
 
Prospective childhood studies that include the maternal prenatal period are limited. Reports 
from the Avon Longitudinal study of parents and Children, discussed above, reported higher BP 
among offspring of both preeclampsia and gestational hypertension pregnancies compared to 
offspring of normotensive pregnancies.28  A secondary analysis from this cohort examined the 
relative contribution of different growth periods to BP level.  At 10 years of age an inverse 
association of birth weight with systolic BP was detected.  In subsequent child growth periods, 
all growth parameters including weight, height, and weight-for-height were positively associated 
with systolic BP, indicating that development of excess adiposity during child growth periods 
was a modifiable determinant of later BP.53  In another small but rigorous prospective study, 
Lurbe et al,54 enrolled healthy full-term infants of uncomplicated pregnancies.  The infants were 
stratified by birth weight as small (SGA), appropriate (AGA) or Large (LGA) for gestational age.  
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BP was measured at 2 days of age was positively associated with birth weight. BP and growth 
parameters were subsequently measured at 6 months, 2 years, and 5 years.  At age 5 years, a 
blood sample was obtained for metabolic parameters including glucose, insulin, and lipids. Each 
birth weight group gained a similar amount of weight between each exam interval. SGA infants 
remained the smallest and LGA infants remained the largest at the subsequent exams. 
Following 6 months, current weight and weight gain were positively associated with birth weight, 
and birth weight was not associated with BP level. At age 5 years the birth weight groups were 
further stratified according to current weight as small average and heavy.  Fasting insulin levels 
were higher in all infants who became heavy at age 5, and were highest among the SGA group.  
However, an estimate of insulin resistance, using the homeostatic model assessment index 
(HOMA), was higher in the entire SGA group regardless of weight status at age 5 years.  Even 
the SGA infants who remained small at age 5 years had measures of insulin resistance that 
were comparable to those who became heavy at age 5 years.  The SGA group also had lower 
high-density lipoprotein-cholesterol (HDL-C) and higher uric acid levels compared to the other 
birth weight groups suggesting metabolic programing related to low birth weight status.  Most 
participants in this cohort were re-examined at age 10 years. In the growth period from age 5 to 
age 10 years the impact of weight gain increased and 22% of children were obese. Children 
with fasting insulin levels >15 U/L had higher office systolic BP, plasma triglyceride and uric 
acid, and lower HDL-C. No children had hypertension based on 24-hour ambulatory BP 
monitoring.  Maternal obesity increased the risk of becoming obese at age 10 years.  These 
reports track and association of early childhood growth with relative insulin resistance and 
higher BP by age 10 years.55 Barker et al.56 linked this childhood growth pattern with 
subsequent cardiovascular events in an analysis of longitudinal population data from Helsinki, in 
which a sample of individuals with coronary heart disease as adults were identified. Adults with 
coronary events had been small at birth and thin at two years of age; but thereafter gained 
weight rapidly and had insulin resistance later in life. These and other reports indicate that a 
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phenotype of lower birth weight paired with developing a high BMI in childhood confers a high 
risk for high BP in childhood and adverse cardio-metabolic outcomes in later adulthood.57   
 
Prematurity, independent of weight for gestational age has been associated with subsequent 
insulin resistance and hypertension in childhood.1  Vohr et al.58 examined a sample (N=379) of 
extreme preterms, with birth weight less than 1000 g, at age 6 to 7 years of age.  Based on 
clinic BP measurements, 20.6% had systolic BP >90th percentile and 10.8% had systolic 
hypertension with comparable rates of abnormal diastolic BP. Children with elevated BP or 
hypertension had higher BMI, triceps skinfold thickness, and waist circumference. Additional 
analysis found that weight gain velocity from 18 months to school age and maternal gestational 
diabetes were associated with high BP in early childhood. Among children with BMI <85th %, the 
prevalence of elevated BP was also high with 17% having high systolic BP and 19% having high 
diastolic BP.  Among the children with BMI <85th %, high BP was associated with public 
insurance and maternal gestational diabetes.  
 
Children born preterm have smaller kidneys, relative to body size, due to lower total nephron 
number. Compared to age-matched normal birth weight children, children born preterm have 
lower glomerular density and lower glomerular volume, based on renal biopsy samples.59   
Raaijmakers et al.60 conducted a study to determine if renin might modulate the incidence of 
hypertension associated with prematurity.  Prematurely born children with birth weights <1000 g 
(N=93) were compared to healthy controls (N=87), at an average age of 11 years.  Renal length 
and renal function, derived from serum cystatin C, were significantly lower in the children born 
preterm (P<0.001).  Systolic and diastolic BP were significantly higher in the preterm born 
children (P<0.001). The odds of having systolic prehypertension among the preterm children 
was 6.43 (2.52 -16.4; P<0.001) and the odds of systolic hypertension among the preterm was 
10.9 (2.46 - 48.4; P<0.002). Plasma renin activity was 0.54 ng/ml per hour lower in the preterm 
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born children than term born controls (P=0.001).  The study findings indicated that hypertension 
in children born extreme preterm is characterized by low renin hypertension, however the 
development mechanism for this finding was unknown. In another study that investigated the 
renin-angiotensin system, South et al.61 quantified angiotensin II and angiotensin-(1-7) in the 
plasma and urine of 175 adolescents born preterm and 51 term born controls.  Prematurity was 
associated with lower plasma angiotensin II and lower angiotensin-(1-7) but overall higher ratio 
of angiotensin II/angiotensin-(1-7) compared to the term born controls. The difference in the 
ratio of angiotensin II/angiotensin-(1-7) was greater in females and individuals with 
overweight/obesity.  BP measurements were not discussed in this report although the authors 
proposed that perinatal renin-angiotensin system programing was more pronounced in females 
and among those with overweight/obesity which would increase their risk for early 
cardiovascular disease. Another study examined young adults born preterm (<29 weeks) with 
age and sex matched controls born at term. Compared to young adults born at term, young 
adults born preterm had significantly higher BP, smaller kidneys, higher urine albumin/creatinine 
ratio, and significantly higher circulating angiotensin I levels (36.3; IQR 13.2-62.3 vs 19.4; IQR 
9.9-26.1 pg/ml, P<001). In this study, there were no group differences in renin, Angiotensin II or 
Ang (1-7).62 Despite differences between studies on components of the renin-angiotensin-
aldosterone system, the very high prevalence of childhood hypertension among children who 
were extremely premature with low birth weight suggest an underlying alteration in 
hemodynamic regulation.  The observation that the prevalence of high BP is increased in the 
presence of excess adiposity suggests that excess postnatal growth augments underlying 





Obesity and diabetes are maternal conditions with heightened risk for childhood obesity and 
higher BP in offspring. During pregnancy, preeclampsia, gestational hypertension and 
gestational diabetes are associated with higher BP as well as excess adiposity in offspring. 
There is now evidence that other exposures including maternal cigarette smoking, air pollution, 
and possible other environment exposures increase the risk for higher BP during childhood 
among offspring. Although genetic factors and familial lifestyles can mediate associations of 
maternal and offspring expression of obesity and high BP, maternal exposures, especially 
prenatal exposures that result in low birth weight and premature birth, may alter the fetal 
intrauterine environment.  The developing fetus can respond to a sub-optimal environment in 
ways to improve survival, with changes in organ size, neuroendocrine changes, or changes that 
involve epigenetic modifications.  However, the adjustments to survival in-utero may not serve 
well in the extra-uterine environment and lead to chronic conditions in later life.  Epigenetic 
alterations indicate modifications in DNA function without changes in DNA sequence through 
DNA methylation, post-translational histone modifications, modifications of nuclear receptors, 
and microRNAs.63,64  Some findings on epigenetic differences associated to prenatal exposures 
have been reported in adults. However, clinical studies that investigate prenatal epigenetic 
modification and outcomes in childhood are limited. One such study by Breton et al.65  
measured DNA methylation of nitric oxide synthase (NOS) and identified an association of 
percent DNA methylation of NOS1 with carotid intimal media thickness in children. Considering 
the many potential adverse exposures and the timing of intrauterine exposure, the fetus may 
experience a treacherous developmental journey to extra-uterine life. Additional research is 
needed, beginning in childhood, that utilizes molecular strategies to map the pathway from 
intrauterine exposures and epigenetic modification to evolution of chronic disease markers. For 
the present time, there are known maternal exposures that increase risk for higher BP in 
childhood, and many of these exposures are linked with accelerated weight gain and excess 
adiposity in childhood. In addition to birth weight, maternal health status both prior to pregnancy 
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and during pregnancy should be included in assessment of elevated BP in children and 
adolescents. 
 
Key Summary Points: 
 
1. Maternal diabetes and obesity are conditions associated with childhood obesity and 
obesity-associated elevated BP in childhood. 
2.  Gestational hypertension and preeclampsia are perinatal exposures associated with 
higher offspring BP in childhood. 
3. Extrinsic exposures including maternal cigarette smoking and maternal exposure to air 
pollution, and assisted reproductive technologies are associated with higher offspring BP 
in childhood. 
4. Causal factors for maternal and gestational influences on childhood BP are genetics, 




Multiple choice questions (answers are provided following the reference list). 
 
1. The most common high risk maternal condition that has been associated with higher BP 
in child offspring is: 
a. Type 2 diabetes 
b. Obesity 
c. Preeclampsia 
d. Air pollution 
 
2. The association of maternal obesity and diabetes with higher BP in child offspring is 
most likely to be: 
a. Directly due to fetal programing 
b. Secondary due to development of obesity in childhood 
c. Directly due to genetic factors 
d. Directly due to maternal age 
 
3. A maternal exposure associated with high BP in childhood that is the result of fetal 
programing is: 
a. Gestational hypertension 
b. Maternal obesity 
c. Assisted reproductive technology 
d. All of above 
 
4.  Maternal and gestational influences on higher BP in child offspring can due to: 
a. Fetal programing 
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b. Genetic factors 
c. Familial life-style factors 
d. All of above 
 
5. A 10 year old boy is referred for suspected hypertension. His BMI is >95th %,  
BP is =90th %, physical exam is otherwise normal, On birth history, birth weight was  
3.2 Kg and mother has type 2 diabetes before and throughout pregnancy.  Additional 
evaluation should include: 
      a.    24 hour ambulatory BP monitoring 
      b.    Lipid panel 
      c.    Diet history 
      d.    No further evaluation needed 
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Answers to questions: 
1. b 
2. b 
3. c 
4. d 
5. a 
 
